Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95%CI) | P-value | HR (95% CI) | P-value | |
Age | 1.026 (1.006–1.046) | 0.009 | 1.030 (1.002–1.060) | 0.038 |
Sex male | 1.195 (0.779–1.832) | 0.414 | ||
serum CA 19-9 (U/mL) > 37 | 2.304 (1.470–3.612) | < 0.001 | 1.633(0.822–3.244) | 0.161 |
Serum CEA (ng/mL) > 5 | 1.904 (1.192–3.041) | 0.007 | 1.674(0.815–3.441) | 0.161 |
Hemoglobin | 1.192 (1.098–1.214) | 0.038 | 1.023 (1.001–1.047) | 0.047 |
NLR > 2.6 | 1.447 (0.963–2.174) | 0.075 | ||
Gallstones | 1.271 (0.821–1.970) | 0.282 | ||
Tumor size > 3 cm | 1.021 (0.639–1.633) | 0.930 | ||
T III–IV | 1.630 (1.253–2.121) | < 0.001 | 0.338 (0.098–1.160) | 0.085 |
Poor differentiation | 2.323 (1.496–3.607) | < 0.001 | 2.050 (1.070–4.300) | 0.042 |
Lymph node metastases | 1.567 (1.004–2.448) | 0.048 | 0.806 (0.388–1.674) | 0.563 |
TNM stage III + IV | 3.688 (2.011–6.764) | < 0.001 | 8.035 (1.708–37.812) | 0.008 |
GNRI < 98 | 3.194 (2.098–4.861) | < 0.001 | 2.207 (1.131–4.308) | 0.020 |